News & Views

Press Releases

New Research on Griffithisin and Carageenan to Prevent HIV and STIs Published in Nature Communications

New Population Council research shows that it may be possible to formulate a discreet, convenient, and woman-controlled multi-purpose technology to prevent HIV and other sexually transmitted infections (STIs) with limited risk of cross-resistance to antiretrovirals (ARV).  This research published today in Nature Communications tests the non-antiretroviral agents, griffithsin (GRFT) and carrageenan (CG), in a fast-dissolving vaginal insert in rhesus macaques and mice.

Read more

Press Releases

FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control

The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control. The approval marks an important step toward expanding contraceptive options for women.

Read more

Press Releases

Jonathan Shakes Joins Population Council Board of Trustees

The Population Council announces the appointment of Jonathan Shakes to the Board of Trustees. Mr. Shakes is an e-commerce logistics consultant, having worked fifteen years in operations, software and product management at Amazon and its subsidiaries.

Read more

Press Releases

Population Council’s One-Year Contraceptive Ring Advances to FDA Review

The Population Council today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its one-year Nestorone® / ethinyl estradiol vaginal ring for pregnancy prevention. If approved, the contraceptive vaginal ring would be the first contraceptive option that provides a full year of protection against unintended pregnancy while fully under a woman’s control.

Read more

Press Releases

Esteemed Dr. Salim S. Abdool Karim Joins Population Council Board of Trustees

The Population Council announces the appointment of leading South African AIDS researcher, Salim S. Abdool Karim, to the Council Board of Trustees. Dr. Karim, a clinical infectious diseases epidemiologist is the Director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), CAPRISA Professor of Global health at Columbia University in New York and Honorary Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal. 

Read more

Press Releases

Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology For HIV and STI Prevention to Clinical Trial

First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products

NEW YORK, NY—The Population Council today announced the enrollment of the first participant in the Phase I clinical trial evaluating PC-6500 (griffithsin in a carrageenan gel), an investigational multipurpose technology to prevent HIV and sexually transmitted infections (STIs), two major threats to sexual health around the world. This is the first in-human study of griffithsin (GRFT), a naturally occurring algae protein that inhibits HIV and other pathogens, including Herpes Simplex Virus (HSV-2).                                                                                                              

Read more

Press Releases

Population Council Awarded Breakthrough-RESEARCH Project by USAID

New York, NY (August 17, 2017) — The Population Council has been awarded Breakthrough-RESEARCH, a five-year cooperative agreement from the U.S. Agency for International Development (USAID). The project aims to improve healthy behaviors and norms across key global health areas, including family planning and reproductive health; HIV/AIDS; maternal, newborn and child health; emerging infectious diseases; and malaria. Led by the Population Council, consortium partners include the Institute for Reproductive Health at Georgetown University, Population Reference Bureau, Tulane University, Avenir Health and ideas42.

Read more